Corpus luteum cells of cats successfully cultivated and comprehensively characterized – Science Codex

The reproduction of lynxes is highly mysterious. Unlike other wild cats, most lynxes are only receptive for a few days once a year. As scientists from the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) have already shown in the past, this is a consequence of the long life of corpus lutea in the ovaries which prevents further ovulation during the course of the year. The Berlin team has now achieved another breakthrough in solving the puzzle: they were able to isolate several cell types of corpus luteum from domestic cat tissue and characterise their function in detail with the help of cell cultures. The new method can also be applied to endangered felids such as the Iberian lynx and could advance our understanding of the causes and mechanisms of the longevity of corpus lutea in lynxes. The ultimate goal in practical terms is to induce ovulation with the help of corpus luteum hormones. This would enhance the support for the reproduction of the highly endangered Iberian lynx in breeding programmes.

When it comes to reproduction, the felids are usually quite unanimous: most wild cat species go through several sexual cycles per year, so can become pregnant several times a year. However, unlike its relatives, the genus Lynx mainly uses a mono-oestric reproduction strategy. Three of four lynx species can become pregnant for a short time only once per year. This is a burden for endangered species such as the Iberian lynx (Lynx pardinus). If they do not succeed in producing offspring within this time, they have to wait until next year. Artificial insemination also failed, probably because of the lack of knowledge about how to induce ovulation. It is therefore indispensable for the success of the lynx conservation breeding programme to learn more about the mysterious physiology of their reproduction.

In 2014, the reproduction team of the Leibniz-IZW was able to present the first important partial solution of the puzzle. Together with colleagues from several zoological gardens they discovered that the corpus luteum of lynx is continuously active for several years and thus responsible for their unusual reproduction pattern. The corpus luteum is a glandular tissue in the ovaries of mammals that, among other things, produces progesterone - the hormone that supports pregnancy and prevents further ovulation. If the egg is not fertilised, the corpus luteum normally degrades quite quickly and thereby enables a new cycle.

"In lynxes, a mechanism has developed that maintains the corpus luteum for several years. This means that the genus Lynx has the longest known lifespan of functionally active corpora lutea among mammals," says Beate Braun, scientist in the Department of Reproduction Biology at the Leibniz-IZW. "It is astonishing that lynxes are ready for reception in a new season despite the presence of corpus lutea. The activity of the corpus luteum is apparently shut down for a short time, which triggers ovulation. Progesterone production is then resumed and held high beyond pregnancy. In this way, the persistent corpus luteum is likely to prevent further ovulations in the same year."

It is still unclear, how exactly the longevity of the corpus luteum is maintained. However, the scientists from Berlin have now come one step closer to solving the mystery. "We succeeded in isolating and cultivating different cell types from the corpus luteum of domestic cats," explains Michal Hryciuk, PhD student in the Department of Reproduction Biology at the Leibniz-IZW. "The cells originate from tissue taken from domestic cats in animal clinics during castration. Tissues from lynxes or other wild cat species are very rarely available - for example when dead animals are found or animals in zoos are castrated for medical reasons. It was therefore important to us to set up a functioning cultivation system first and then apply it to valuable samples, and that is exactly the system that we have now."

The scientists not only succeeded in cultivating several cell types but also characterised large and small cells of corpus lutea under controlled laboratory conditions. They were able to determine the amount of progesterone and other hormones produced and track the changing activity of genes over time. With the developed cultivation technique, scientific research now has the urgently needed instruments at its disposal to solve the riddle of the long-lived corpus luteum. "Our results will help to identify the hormonal control mechanisms that regulate the growth, maintenance, and degradation of corpus luteum," says Katarina Jewgenow, Head of the Department of Reproduction Biology at the Leibniz-IZW. "This opens up completely new possibilities to enhance the conception of endangered lynxes and other wild cat species in order to support conservation breeding programmes."

The rest is here:
Corpus luteum cells of cats successfully cultivated and comprehensively characterized - Science Codex

Winding the body’s clock – Knowable Magazine

Long before Apple watches, grandfather clocks or even sundials, nature provided living things with a way to tell time.

Life evolved on a rotating world that delivered alternating light and darkness on a 24-hour cycle. Over time, cellular chemistry tuned itself to that rhythm. Today, circadian rhythms governed by a master timekeeper in the brain guide sleeping schedules and mealtimes and influence everything from diet to depression to the risk of cancer. While an Apple watch can monitor a few vital functions such as your heart rate, your bodys natural clock controls or affects nearly all of them.

Circadian rhythms impact almost every aspect of biology, says neuroscientist Joseph Takahashi of the University of Texas Southwestern Medical Center.

Lately, research by Takahashi and others has suggested strategies for manipulating the bodys clock to correct circadian-controlled chemistry when it goes awry. Such circadian interventions could lead to relief for shift workers, antidotes for jet lag, and novel treatments for mood disorders and obesity, not to mention the prospect of counteracting aging.

Prime weapons for the assault on clock-related maladies, Takahashi believes, can be recruited from an arsenal of small molecules, including some existing medical drugs.

Researchers are increasingly interested in developing small molecules to target the circadian system directly for therapeutic gains, Takahashi and coauthors Zheng Chen and Seung-Hee Yoo wrote in the 2018 Annual Review of Pharmacology and Toxicology.

In sophisticated life-forms (such as mammals), central control of the bodys clock resides in a small cluster of nerve cells within the brains hypothalamus. That cluster, called the suprachiasmatic nucleus SCN for short is tuned to the day-night signal by light transmitted via the eyes and the optic nerve.

But the SCN does not do the job alone. Its the master clock, for sure, but satellite timekeepers operate in all kinds of cells and body tissues.

There isnt just an SCN clock in the brain, Takahashi said at a recent meeting of the Society for Neuroscience. There are clocks throughout the entire body. Every major organ system has its own intrinsic clock.

The proliferation of clocks throughout the body makes circadian chemistry relevant to various behaviors and physiological processes, such as metabolism and blood flow. Maintaining healthy physiology requires all the bodys various clocks to be synchronized by signals (in the form of hormones and nerve impulses) from the SCN. SCN signals govern the timing of genetic activity responsible for the production of numerous clock-related proteins. Studies mainly in mice have shown how those proteins participate in complex chemical feedback loops, perpetuating rhythmic genetic activity in which proteins are first produced and then degraded to drive circadian cycles. Similar chemistry operates in humans.

Key molecular players in keeping the bodys clocks ticking are the proteins known as CLOCK and BMAL1. Studies of liver cells in mice show that CLOCK partners with BMAL1 to regulate gene activity, driving all the important circadian chemical reactions. Generally in many cells you see a similar kind of picture, in the brain or other tissues, Takahashi said.

The CLOCK-BMAL1 tandem activates genes that produce several forms of the circadian proteins period and cryptochrome. In mice, that process starts work in daytime, leading to a substantial buildup of period (PER) and cryptochrome (CRY) by evening. At night, PER and CRY migrate into the cells nucleus and block the action of CLOCK-BMAL1, thereby halting production of PER and CRY themselves. PER and CRY amounts then diminish as other molecules degrade them. By morning, PER and CRY levels drop so low that CLOCK and BMAL1 are no longer disabled and can begin producing PER and CRY anew.

Many other molecules participate in circadian chemistry; the exact molecular participants differ from tissue type to tissue type. In the (mouse) liver alone, the activity of thousands of genes fluctuates on a circadian schedule.

An hourglass uses the flow of sand to mark time. The body uses the build-up and flow of proteins to keep its rhythms. Although there are numerous different players in the bodys many clocks, the workings of the circadian proteins period (PER) and cryptochrome (CRY) (and their counterparts CLOCK and BMAL1) exemplify the kind of feedback loop that keeps the body in sync with the day-night cycle.

While signals from the SCN set the daily schedule for circadian chemistry, various small molecules, such as many medicinal drugs, can disrupt cellular timing. (Thats one reason certain drugs such as blood thinners and chemotherapy treatments are more or less effective depending on the time of day that they are administered.) Researchers have identified dozens of small molecules that can influence circadian processes.

Some such molecules change the length of the circadian period. Some alter the precise timing of specific processes during the cycle. Others help maintain robust signals for synchronizing the bodys clocks. Circadian signaling weakens with age, possibly contributing to many age-related disorders such as impaired metabolism or sleep problems.

Among the common drugs that exert effects on the circadian system are opsinamides, sulfur-containing compounds that suppress the amount of light input into the SCN. Nobiletin, found in the peels of citrus fruits, manipulates circadian rhythms to improve metabolism in obese mice. (Nobiletin also counters tumors and inflammation.) Resveratrol is a well-known compound that alters the activity of certain clock genes, with some possible human health benefits.

Scientists have discovered a long list of existing medicines and small molecules now under investigation that act on or influence the bodys circadian system.

Todays challenge, Takahashi and coauthors say, is to identify the precise targets where small molecules exert their influence. Knowing the targets should help researchers find ways to repair defects in the circadian system or alleviate temporary inconveniences such as jet lag.

Jet lag occurs when sudden changes in time zone generate a mismatch between the body clocks expectations and the actual day-night cycle (not to mention timing of meals and social activities). While it is usually just an annoyance for travelers, shift workers face long-term consequences for working when the body clock advises sleep. Shift workers, Chen, Yoo and Takahashi point out, are at risk for sleep problems, gastrointestinal disorders, obesity, cardiovascular disease, cancer and mood disorders. Molecules tested in mice have shown promise for reconciling expectations with reality, getting the clock back in phase with the bodys environment.

Clock malfunction also affects the bodys disease-fighting immune system, and certain clock components have been identified as potential targets for alleviating autoimmune disease and excessive inflammation. Other recent studies have shown that molecular intervention with clock components can aid proper functioning of mitochondria, the cellular structures responsible for energy production.

While most of the details about circadian chemistry come from studies in mice, studies of human sleep disorders indicate that the basic circadian story is similar in people. A mutation in the human gene responsible for making one of the period proteins has been linked, for example, to familial advanced sleep phase disorder. (In people with that mutation, the normal sleep-wake cycles shift by several hours.) Other research has shown that a variant version of the human gene for cryptochrome protein increases the risk of diabetes.

An especially intriguing possibility is that body clock management could provide strategies for slowing down aging.

Many studies have shown that aging in some animal can be slowed by restricting food intake. Fewer calories can lead to longer lives. But work by Takahashi and others has found that (in mice, at least) timing of ingesting the calories can be almost as important as the quantity.

Mice allowed to eat a normal amount of calories, but only within restricted hours, have lived about 15 percent longer than usual, Takahashi reported at the neuroscience meeting. In humans, that would correspond to a life span increase from 80 years to 92.

Were super excited about these results, because these are the first experiments to show that you can extend life span by restriction of time of nutrient intake only without a reduction of calories, Takahashi said.

For us its much easier to restrict the time that we eat than the amount that we eat. Now if you can do both, thats even better. I think that this, I hope, could have benefit for human health and longevity in the future.

Continue reading here:
Winding the body's clock - Knowable Magazine

Associate Professor in Psychology of Physical Activity and Health job with COVENTRY UNIVERSITY | 190233 – Times Higher Education (THE)

Application closing date:13/01/2020Faculty / School or Service:Faculty of Health and Life SciencesSalary:51,044.00 - 63,684.00 per annumPackage:As one of Coventry's biggest employers, we offer some pretty impressive benefits including an excellent pension scheme and generous holiday allowances.Job category/type:Academic

Job description

Research within the Centre for Sport, Exercise and Life Sciences (CSELS), at Coventry University, reflects a broad range of sport, exercise and biological sciences to understand life from the molecular level through to the whole body. The Centre has considerable expertise, ranging from microbiology, cell biology, genomic and molecular biology, biochemistry,nutritionand food science, safety pharmacology, physiology, physical activity and sport performance.

As part of Coventry Universitys Research Strategy 2021 it is increasing its investment in quality research excellence with impact. As a result the Centre is looking to appoint a range of senior academic staff to provide strategic leadership in the management of our research. The fields of research expertise include; Therapeutics and Disease Prevention, Clinical and Molecular Exercise Physiology and Physical Activity, Exercise and Sport.

The following vacancies are currently available:

The successful candidates will have a PhD in a relevant subject, along with a track record of securing significant external funding and a substantial record of research and publications or other forms of dissemination (such as policy advice) in a relevant field, commensurate with a 3* REF rating. The post holders would be expected to have an international reputation with the ability to attract world-class academics to collaborate within their field of Research.

In addition you will be expected to seek and obtain funding to support the development of further research activities, conduct and publish original research and supervise research students working in this field. Developing the academic and commercial potential within the Centre to ensure this continues to reflect the leadership of Interdisciplinary Research whilst delivering excellence with impact in line with our Corporate Strategy.

These role provides a unique opportunity to join one of the UKs most forward thinking and successful modern Universities at a time of rapid expansion in our research capacity. The positions will be based in our new purpose-built research laboratories on the Coventry city campus.

If would like to find out more about this exciting opportunity please contact, Executive Director of the Centre, Professor Helen Maddockhelen.maddock@coventry.ac.ukTo find out more about our work and to tell us more about how you can contribute, visit ourwebsite

Click here for Job Description and Person Specification

See original here:
Associate Professor in Psychology of Physical Activity and Health job with COVENTRY UNIVERSITY | 190233 - Times Higher Education (THE)

Study suggests obesity associated with greater greenhouse gas emissions – Newswise

MEDIA CONTACT

Available for logged-in reporters only

Newswise SILVER SPRING, Md.--A new analysis suggests that the increasing average body size of people on Earth, in addition to the growing world population may further challenge attempts to reduce man-made carbon dioxide emissions, according to a paper published online inObesity, the flagship journal of The Obesity Society.

All oxygen-dependent organisms on the planet produce carbon dioxide as a result of metabolic processes necessary to sustain life. Total carbon dioxide production from any species is linked to the average metabolic rate, the average body size and the total number of individuals of the species.

People with obesity have greater carbon dioxide production from oxidative metabolism than individuals with normal weight. Also, maintenance of greater body weights requires more food and drinks to be produced and transported to the consumers. Similarly, transportation of heavier people is associated with increased consumption of fossil fuels. This results in additional carbon dioxide emissions related to food production and transportation processes. Globally, obesity was estimated to contribute to an extra 700 megatons of carbon dioxide emissions per year or about 1.6 percent of all man-made emissions.

The authors emphasize that it is critically important that this new information does not lead to more weight stigmatization. People with obesity already suffer from negative attitudes and discrimination, and numerous studies have documented several prevalent stereotypes.

"This study makes it clear that we pay a steep price for making it difficult to access care for obesity. Not only does obesity affect the health of the individuals who have it, untreated obesity might also contribute to environmental issues," said Ted Kyle, RPh, MBA, founder of ConscienHealth, who was not involved in the research.

Physical activity is also associated with much more carbon dioxide being produced compared with rest, but no one will ever think of stigmatizing people who exercise for having a negative effect on the environment, according to Boyd Swinburn, MB ChB, FRACP, MD, FNZCPHM, in the School of Population Health at the University of Auckland in New Zealand. Swinburn wrote a commentary on the paper.

"Our analysis suggests that, in addition to beneficial effects on morbidity, mortality, and healthcare costs, managing obesity can favorably affect the environment as well," said Faidon Magkos, of the Department of Nutrition, Exercise and Sports at the University of Copenhagen in Denmark. "This has important implications for all those involved in the management of obesity." Magkos is the corresponding author of the paper.

To assess the impact of obesity on the environment, researchers used the standard definitions of obesity (body mass index of greater than or equal to 30 kg/m2) and normal weight (body mass index of less than 25). Calculations were made of the extra emission of greenhouse gases (carbon dioxide, methane, and nitrous oxide) from the increased oxidative metabolism, the increased food production and consumption and the increased fuel used to transport the greater body weight of people with obesity.

Compared with an individual with normal weight, researchers found an individual with obesity produces an extra 81 kg/y of carbon dioxide emissions from higher metabolism, an extra 593 kg/y of carbon dioxide emissions from greater food and drink consumption and an extra 476 kg/y of carbon dioxide emissions from car and air transportation. Overall, obesity is associated with approximately 20 percent greater greenhouse gas emissions when compared to people with normal weight.

"Harmonizing data from epidemiology (prevalence rates of obesity), physiology (total energy intake and expenditure) and environmental science (carbon dioxide emissions from different sources) is not a straightforward task, and we emphasize that our estimates are not intended to be precise, but rather be reasonable enough," said Magkos.

In the commentary accompanying the paper, Swinburn said the estimates add valuable information to the growing literature examining the nexus between obesity and climate change. He added, "while the contribution of obesity to greenhouse gas emissions is small, acting on the underlying drivers of them both is of paramount importance."

###

Other authors of the study include Inge Tetens, Simon Ronnow Schacht, Susanne Gjedsted Bgel and Arne Astrup of the Department of Nutrition, Exercise and Sports at the University of Copenhagen in Denmark. Claus Felby of the Department of Geosciences and Natural Resource Management at the University of Copenhagen also co-authored the paper. Other authors include James Hill of the University of Alabama at Birmingham and Eric Ravussin of Louisiana State University's Pennington Biomedical Research Center in Baton Rouge, La.

The study, titled "The Environmental Foodprint of Obesity" will be published in the January 2020 print issue.

The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects. Combining the perspective of researchers, clinicians, policymakers and patients, TOS promotes innovative research, education, and evidence-based clinical care to improve the health and well-being of all people with obesity. For more information, visithttp://www.obesity.organd connect with us onFacebook,TwitterandLinkedIn.

See the original post here:
Study suggests obesity associated with greater greenhouse gas emissions - Newswise

Dr. Sam Brooks, pioneer in breast cancer research, dies at 91 – The South End

Samuel Carroll Brooks Jr., Ph.D., a retired professor of Biochemistry at the Wayne State University School of Medicine, died Dec. 15 after a battle with cancer.

Dr. Brooks, a resident of Steamboat Springs, Colo., was a faculty member from 1959 to 2006. He was widely known for his scientific and scholarship contributions to

breast cancer research. He was the first to describe the estrogen receptor in breast cancer cell line MCF-7, the first human breast cancer cell line produced. He characterized the line, and was instrumental in recognizing the importance of the estrogen receptor in regulating breast cancer growth. This research led to the development of a clinical laboratory test for estrogen receptor used to determine which patients are eligible for treatment with anti-estrogen drugs.

He also worked to characterize the MCF10 cell line that led to the first continuously growing line of human pre-neoplastic breast cells, which allow researchers to study the earliest events in breast cancer progression and to test strategies to interfere with those events.

He was a charter member of the WSU Academy of Scholars, and made many contributions on behalf of the university, School of Medicine, Cancer Biology, Oncology, Faculty Senate, medical school admissions and his Department of Biochemistry.

Dr. Brooks is survived by Frieda Brooks, his wife of 58 years; children Katie Brooks Robertson and husband Mike of Fishers, Ind., and Carroll Brooks and wife Jamie of Seoul, South Korea; grandchildren Samuel, Phillip, Jake, Lauren and Ben; and many nieces and nephews. He was preceded in death by his brother James Webster Brooks and son James Winfried Brooks.

Dr. Brooks was born and raised in Winchester, Va. He received his bachelors degree from Carnegie Mellon University and masters and doctorate degrees from the University of Wisconsin-Madison. He served in the United States Army and was promoted from Lieutenant to Captain during the Korean War.

In his free time, Dr. Brooks enjoyed traveling, skiing, reading WWII history novels, watching Wisconsin Badgers football and spending time with family and friends. He will be fondly remembered for his kindness, sense of humor, knack for storytelling, and his love of animals.

A celebration of life will take place at 11 a.m. Dec. 29 at St. Martin-Tours Catholic Church, 400 Sharp Ave., in Oak Creek, Colo. Memorial contributions may be made in his name to the Boys & Girls Clubs of Northwest Colorado, 325 7th St., Steamboat Springs, CO. 80487.

Link:
Dr. Sam Brooks, pioneer in breast cancer research, dies at 91 - The South End

Badillo Lab Receives Research Grant from the Sloan Foundation – Seton Hall University News & Events

Graduate student Jason Sway setting up a photochemical reaction in McNulty Hall.

The Badillo Lab is invigorating Seton Hall's presence in the Synthetic Organic Community! The Badillo Lab recently received a $10,000 SEED grant from the Sloan Scholars Mentoring Network with funds coming from the Alfred P. Sloan Foundation. The grant supports the group's research on developing photoacid catalysis for organic synthesis. The group uses visible light to access excited state molecules up to a million times more acidic than in their ground state to enable previously inactive molecules to function as catalysts for new reactions. These photoactivated catalytic processes consume only photons, making photoacid catalysis a greener option to alternative methods.

Their work titled "Photoacid-Catalyzed FriedelCrafts Arylation of Carbonyls" was recently published in Organic Letters (Org. Lett. 2019, 21, 21, 8528-8532, 10.1021/acs.orglett.9b02841)."We are extremely grateful to the SSMN and the Sloan Foundation for supporting our work,"says Dr. Joseph Badillo (Assistant Professor, Department of Chemistry and Biochemistry). Dr. Badillo joined the faculty at Seton Hall in 2017, after completing his postdoctoral studies at Princeton University in the laboratory of Professor Dave MacMillan. Zena Salem (B.S. Biology, Chemistry minor), who is first author on the article, was the recipient of an Undergraduate Summer Research Fellowship from the New Jersey Space Grant Consortium (NJSGC) and NASA. Zena expressed, "Having the support from the NJSGC and NASA allowed me to focus on research!"

Undergraduate student Zena Salem (left) and graduate student Jason Saway (right) won best poster at the 2019 Department of Chemistry and Biochemistry Petersheim Academic Exposition.

Representing the Badillo Lab, Zena Salem and Jason Saway (Ph.D. Chemistry) won best undergraduate and graduate poster presentation, respectively, at the 2019 Department of Chemistry and Biochemistry Petersheim Academic Exposition. Badillo's group also recently traveled to the University of Maryland to present their work at the 2019 Alliance for Diversity in Science and Engineering (ADSE) 8th Annual Young Research Conference. Zena Salem won first place speaker award for best oral presentation, "Zena was the only undergraduate speaking with graduate students and faculty from top tier institutions, such as NYU and John Hopkins, I am extremely proud of her accomplishments, she has a bright future!"says Dr. Badillo. The ADSE's mission is to increase the participation of underrepresented groups in academia, industry, and government. Dr. Badillo asserts, "I have a long-standing interest in promoting diversity in STEM."

Recent chemistry graduate Desiree Harris presents her research at the 2019 NOBCChE National Meeting.

Furthermore, Desiree Harris (B.S. Biochemistry 2019) represented Seton Hall and the Badillo Lab at the 2019 National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) National Conference in St. Louis, MO. Desiree expressed her excitement after returning from the conference stating, "NOBCChE was eye-opening! It wasan honor to be amongst a cadre of such distinguished professionals in the field." Darwin Glynn (B.S. Biology, Chemistry minor) from the lab was awarded a 2019 Independent College Fund of New Jersey (ICFNJ) Scholarship and an NJSGC and NASA Fellowship. Sam Chalet (B.S. Chemistry and Biology), received a Claire Boothe Luce (CBL) Mid-Career Award and a CBL Summer Research Award.Darwin, Sam, and Zena represented Seton Hall at the 2019 ICFNJ Undergraduate Research Symposium at the Liberty Science Center in Jersey City. Finally, Darwin and Zena represented SHU at the 13th annual William Paterson Undergraduate Research Symposium. "I'm proud of my students and all their hard work, the accolades they are receiving are well deserved!"said Dr. Badillo. "Having Dr. Badillo as a mentor has opened my eyes to research avenues I never imagined, and his mentorship is the reason our group is so productive. We are looking forward to another successful year in 2020!"said Jason.

Original post:
Badillo Lab Receives Research Grant from the Sloan Foundation - Seton Hall University News & Events

Scientists find way to supercharge protein production – Washington University in St. Louis Newsroom

Medicines such as insulin for diabetes and clotting factors for hemophilia are hard to synthesize in the lab. Such drugs are based on therapeutic proteins, so scientists have engineered bacteria into tiny protein-making factories. But even with the help of bacteria or other cells, the process of producing proteins for medical or commercial applications is laborious and costly.

Now, researchers at Washington University School of Medicine in St. Louis have discovered a way to supercharge protein production up to a thousandfold. The findings, published Dec. 18 in Nature Communications, could help increase production and drive down costs of making certain protein-based drugs, vaccines and diagnostics, as well as proteins used in the food, agriculture, biomaterials, bioenergy and chemical industries.

The process of producing proteins for medical or commercial applications can be complex, expensive and time-consuming, saidSergej Djuranovic,associate professor of cell biology and physiology and the studys senior author. If you can make each bacterium produce 10 times as much protein, you only need one-tenth the volume of bacteria to get the job done, which would cut costs tremendously. This technique works with all kinds of proteins because its a basic feature of the universal protein-synthesizing machinery.

Proteins are built from chains of amino acids hundreds of links long. Djuranovic and first author Manasvi Verma, an undergraduate researcher in Djuranovics lab, stumbled on the importance of the first few amino acids when an experiment for a different study failed to work as expected. The researchers were looking for ways tocontrol the amount of protein produced from a specific gene.

We changed the sequence of the first few amino acids, and we thought it would have no effect on protein expression, but instead, it increased protein expression by 300%, Djuranovic said. So then we started digging in to why that happened.

The researchers turned to green fluorescent protein, a tool used in biomedical research to estimate the amount of protein in a sample by measuring the amount of fluorescent light produced. Djuranovic and colleagues randomly changed the sequence of the first few amino acids in green fluorescent protein, generating 9,261 distinct versions, identical except for the very beginning.

The brilliance of the different versions of green fluorescent protein varied a thousandfold from the dimmest to the brightest, the researchers found, indicating a thousandfold difference in the amount of protein produced. With careful analysis and further experiments, Djuranovic, Verma and their collaborators from Washington University and Stanford University identified certain combinations of amino acids at the third, fourth and fifth positions in the protein chain that gave rise to sky-high amounts of protein.

Moreover, the same amino-acid triplets not only ramped up production of green fluorescent protein, which originally comes from jellyfish, but also production of proteins from distantly related species like coral and humans.

The findings could help increase production of proteins not only for medical applications, but in food, agriculture, chemical and other industries.

There are so many ways we could benefit from ramping up protein production, Djuranovic said. In the biomedical space, there are many proteins used in drugs, vaccines, diagnostics and biomaterials for medical devices that might become less expensive if we could improve production. And thats not to mention proteins produced for use in the food industry theres one called chymosin that is very important in cheese-making, for example the chemical industry, bioenergy, scientific research and others. Optimizing protein production could have a broad range of commercial benefits.

Originally published by the School of Medicine

Read the original here:
Scientists find way to supercharge protein production - Washington University in St. Louis Newsroom

3D Cell Culture Market: Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation – Global Forecast to 2024 – ResearchAndMarkets.com -…

DUBLIN--(BUSINESS WIRE)--The "3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

The 3D cell culture market is projected to reach USD 1,846 million by 2024 from USD 892 million in 2019, at a CAGR of 15.7%

The growth in this market is primarily driven by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to limit market growth during the forecast period.

The microfluidics-based 3D cell cultures segment is projected to grow at the highest CAGR during the forecast period.

Based on product, the 3D cell culture market is segmented into scaffold-based, scaffold-free, microfluidics-based, and magnetic & bioprinted 3D cell cultures. The microfluidics-based segment is expected to register the highest CAGR during the forecast period. Funding initiatives from various government and private investors are among the key factors driving the growth of this market.

Cancer and stem cell research segment accounted for the largest share of the 3D cell culture market in 2018.

On the basis of application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell research segment accounted for the largest share of the market in 2018. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government as well as the private sector are some of the major factors driving the growth of this application segment.

Europe to witness high growth during the forecast period.

Based on the region, the 3D cell culture market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The European market is expected to grow at the highest CAGR owing to the growth of the pharmaceutical and biotechnology industry, increasing incidence of cancer, growing number of venture capital investments, strategic expansion of market players in the region, recent commercialization of microfluidic-based products, increasing presence of major market players, and the large number of research activities in the region.

Market Dynamics

Market Drivers

Restraints

Opportunities

Challenges

Company Profiles

Other Key Players

For more information about this report visit https://www.researchandmarkets.com/r/aj5kod

Visit link:
3D Cell Culture Market: Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation - Global Forecast to 2024 - ResearchAndMarkets.com -...

Graduating with a master’s degree AND a medical discovery – Science at ANU

For her masters degree in biotechnology, Pallavi Venkatesh didnt just learn about the latest advances in medical science, she made some too.

Pallavi studied one of the most important tools in modern medicine, the Vaccinia virus, which was used as a vaccine to eradicate smallpox.

I found out that different strains of the virus preference different pathogen-sensing molecules found within immune cells, which is really exciting, she says.

Better understanding how different virus strains are detected by immune cells could help fine-tune its use as a tool against cancers and other viruses in the future.

Our finding was exciting as we found that more than one of these pathogen sensor molecules was involved and that different strains may activate different sensor molecules preferentially.

Pallavi says the coursework components of her Master of Biotechnology (Advanced) at The Australian National University (ANU) gave her the skills she needed to undertake this original research.

I studied genomic sciences, molecular biology and cell biology, which I really enjoyed, she says.

For the research component of her degree, she had the opportunity to be part of an innovative team at The John Curtin School of Medical Research (JCSMR).

I did my research under David Tscharke in the Immunology Department, she says.

Working with David was an amazing learning opportunity, he pushes you to be the best you can and provides incredible support.

I also received additional support from members of the lab which helped me through my research year.

Prior to arriving at ANU, Pallavi completed her undergraduate degree at Jyoti Nivas College in Bangalore.

She says that Canberra and living on campus at Toad Hall provided the ideal environment for a postgraduate scholar.

I highly recommend ANU as a place to study, she says. I made lots of new friends here, friends for life.

Inspired by her time at JCSMR, Pallavi is now planning to pursue a career in immunology.

Find out more about how a Master of Biotechnology at ANU can help launch your career in medical, biological or agricultural science.

See more here:
Graduating with a master's degree AND a medical discovery - Science at ANU

Augustinus Bader’s The Cream Review – MarieClaire.com

Welcome back to Worth It, a bi-weekly breakdown of the new beauty products Ive tested and adored: Im talking that drain-it-to-the-bottom-and-tell-my-friends-Ive-found-The-One kind of love. If it's featured here, consider this my permission to splurge on it. Read on for the product you dont want to live without, and catch up on the latest Worth It breakdown here.

Courtesy

The Cream

$170.00

When you try The Cream, it comes at a price. You know, not your soul or an Infinity Gauntlet situation, but it's hefty nonetheless: $265 for 50 mls of the world-famous lotion. That said, its a skincare nerds dream. Bader, a professor and director of Applied Stem Cell Biology and Cell Technology at the University of Leipzig in Germany, is considered the top scientist in the world on the subject of regenerative tissue. His work, particularly his extensive studies on disfiguring burns and wound healing, led him to create the illustrious cream: The formulas secret is its TFC8 (Trigger Factor Complex 8), a proprietary blend that the brand says will activate the bodys own stem cells to promote major anti-aging benefits like minimized lines, even tone, and redness-reduction.

Ive been aware of the product's cult-status for years, but I honestly just tried it for shits-and-gigs. My skin is typically easily managed: I get ruddy and dry, and I tend to develop tiny, under-the-skin bumps on my cheeks after I sleep on hotel sheets (should I forget my Slip pillowcase). On rare occasions, Ill wake up with a pimple thats so mountainous and painful that I wonder if I contracted staph on the F train. But for the most part, I have good skin, and Im grateful for it. Thats why I typically seek out products that impart glowiness and hydration rather than something to totally overhaul my facebut that's exactly what The Cream claims to do.

Despite my dry skin type, I chose the original formula rather than the Rich Cream (I prefer lighter textures when it comes to moisture). I also didnt adhere to the proper instructions: Bader recommends using it for 27 days, minimum, with no additional skincare products except for cleanser, but I couldnt bring myself to abandon the rest of my arsenal. Instead, I used this as my last step in both my morning and evening routines.

My makeup went on smoothly in the mornings, but my off-dry skin never felt truly quenched before bed unless I applied a hydrating serum underneath. Meh. Yet, after about three weeks, I started to receive an onslaught of complexion compliments. I guess I havent looked as red recently, I thought. And I didnt have any active pimples, so I didnt think much of it. Ill take a good skin week anytime.

But one morning, mid-glam, I realized Id forgotten to apply both foundation and concealer and had gone straight for my Nudestix blush stick. I genuinely couldnt tell if Id put my complexion makeup on. Peter Parker getting stuck to the ceiling on his first morning as Spiderman? Same level of confusion. I took a closer look, skeptical. Do I look amazing?

Rather than that translucent, un-plump look my skin usually has in the morning, it appeared stronger, almost thicker. My fair tone was even and clear, and my typical little dark circles were nowhere to be found, seemingly buried underneath my reinforced complexion.

I do. I look fucking amazing.

I suddenly felt invinciblelike my own more stunning evil twin, or a supervillain whod traded their lovers heart for immense power and was rewarded with that golden, CGI glow-from-within that comes with Marvel-sanctioned immortality. I was transformed, and the expensive blue bottle on my dresser was the precious source of my new supremacy.

Ive been using The Cream ever since (about three months now) and my complexion has a whole new baseline. When people ask if it's really worth it, rather than offer a cheaper alternative like I typically do with products this expensive, I answer: This shit is wild.

For more stories like this, including celebrity news, beauty and fashion advice, savvy political commentary, and fascinating features, sign up for the Marie Claire newsletter.

subscribe here

Read more:
Augustinus Bader's The Cream Review - MarieClaire.com